Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Osteosarcoma and XPA[original query] |
---|
Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients. The pharmacogenomics journal 2009 Oct 9 (5): 347-53. Caronia D, Patiño-García A, Milne R L, Zalacain-Díez M, Pita G, Alonso M R, Moreno L T, Sierrasesumaga-Ariznabarreta L, Benítez J, González-Neira |
Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy. The pharmacogenomics journal 2012 Dec 12 (6): 476-83. Biason P, Hattinger C M, Innocenti F, Talamini R, Alberghini M, Scotlandi K, Zanusso C, Serra M, Toffoli |
Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma. International journal of clinical and experimental pathology 2015 8 (7): 7905-12. Sun Yongjian, Wu Yi, Li Weicheng, Kong Zhen, Zou Xiaomi |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: